ANDROLIC (Oxymetholon) 50 mg
Androlic (Oxymetholon) 50 mg ist ein starkes orales anaboles Steroid, das nur für den wissenschaftlichen Gebrauch bestimmt ist. Jede Tablette enthält 50 mg Oxymetholon. Geliefert in einer 100-Tabletten-Packung. Nur für Laborforschung und chemische Referenzzwecke.
€ 59.00
Beschreibung
ANDROLIC (Oxymetholon) 50 mg
Marke: The British Dispensary Co. LTD
Kategorie: Oral AAS Research Compound
Inhalt: 100 tablets | 50 mg per tablet
Preis: €59
Hergestellt in: Thailand
🧪 Produktübersicht
Oxymetholone 50 mg, commercially known as ANDROLIC, is a structurally modified
17-α-alkylated dihydrotestosterone (DHT) derivative developed for hematologic and androgen-receptor (AR)
modulation research. Its strong anabolic index, erythropoietic activity, and well-documented hepatic risk profile
make it a key reference standard in studies of AR signaling, EPO regulation, and steroid toxicology.
Originally used clinically for anemia, oxymetholone has shown notable increases in erythropoietin (EPO),
red-cell mass, and protein-synthesis pathways. Its 17-α-alkylated structure enhances oral bioavailability
while elevating hepatotoxicity risk, supporting reproducible liver-injury modeling.
✅ Die wichtigsten Forschungsergebnisse
Enhanced erythropoiesis:
FDA and NCBI data confirm increased erythropoietin and hematologic output.
Potent AR agonism:
Strong anabolic transcriptional signaling suitable for AR-targeted assays.
High oral stability with hepatic strain:
17-α-alkylation increases bioavailability but introduces significant hepatotoxicity.
Endocrine & metabolic effects:
Dyslipidemia, suppression of endogenous hormones, fluid retention, and virilization endpoints.
🧬 Empfohlene Laboranwendungen
- Hematologic stimulation modeling (EPO & red-cell regulation)
- Androgen receptor activation & gene-transcription studies
- Anabolic-androgenic steroid toxicology
- Hepatic injury modeling (peliosis, cholestasis, tumor pathways)
- Comparative anabolic potency benchmarks
📊 Technische Daten
| Feld | Daten |
|---|---|
| Chemische Bezeichnung | Oxymetholone |
| Chemische Formel | C21H32O3 |
| Synonyme | Anadrol; Anapolon; 17α-Methyl-2-hydroxymethylene-17β-hydroxy-5α-androstan-3-one |
| Molekulargewicht | ≈ 332.48 g/mol |
| CAS-Nummer | 434-07-1 |
| Mechanistic Class | 17-α-alkylated DHT derivative; AR agonist; EPO stimulator |
| Dokumentierte Vorteile | ↑ EPO, ↑ red-cell mass, ↑ anabolic transcription, ↑ protein synthesis |
| Hauptrisiken | Hepatotoxicity (peliosis, tumors), cholestasis, dyslipidemia, endocrine suppression, edema |
| Detection Considerations | WADA S1 classification — prohibited in all doping contexts |
| Haltbarkeitsdauer | 36 Monate |
❄️ PubChem-gestützte Forschungseinblicke
- Strong AR agonist with high transcriptional activity
- Enhances erythropoietin through androgen-mediated signaling
- Marked hepatic strain due to 17-α-alkylation
- Valuable as a toxicology reference in steroid metabolism studies
- Affects lipid regulation and endocrine pathways
⚠️ Dokumentierte Forschungsnebenwirkungen
- Hepatic tumors, peliosis hepatis, cholestatic jaundice (FDA warnings)
- Dyslipidemia (↑ LDL / ↓ HDL)
- Edema and altered fluid retention
- Suppression of endogenous testosterone
- Virilization endpoints in androgen-sensitive models
🧯 Handhabung und Einhaltung
Nur für Forschungszwecke — Not for human or veterinary application.
Store dry, protected from light, below 30 °C.
Aufgeführt unter WADA S1 prohibited anabolic agents.
Kauf bestätigt qualifizierte Forscherin status.
Es sind noch keine Bewertungen vorhanden.
